H Monrroy1, D Cisternas2, C Bilder3, A Ditaranto3, J Remes-Troche4, A Meixueiro4, M A Zavala4, J Serra5, I Marín5, A Ruiz de León6, J Pérez de la Serna6, A Hani7, A Leguizamo7, L Abrahao8, R Coello9, M A Valdovinos10. 1. Department of Gastroenterology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. 2. Universidad del Desarrollo, School of Medicine, Clínica Alemana de Santiago, Santiago, Chile. 3. Hospital Universitario, School of Medicine, Fundación Favaloro, Buenos Aires, Argentina. 4. Universidad Veracruzana, Veracruz, México. 5. Motility and Functional Gut Disorders Unit, University Hospital Germans Trias i Pujol, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd); Department of Medicine, Autonomous University of Barcelona, Badalona, Spain. 6. Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain. 7. San Ignacio Hospital Pontificia Universidad Javeriana, Bogotá, Colombia. 8. University Hospital Clementino Fraga Filho, Rio de Janeiro, Brazil. 9. Axxis Hospital, Quito, Ecuador. 10. Motility Lab, Department of Gastroenterology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico.
Abstract
OBJECTIVES: High-resolution manometry (HRM) is the preferred method for the evaluation of motility disorders. Recently, an update of the diagnostic criteria (Chicago 3.0) has been published. The aim of this study was to compare the performance criteria of Chicago version 2.0 (CC2.0) vs. 3.0 (CC3.0) in a cohort of healthy volunteers and symptomatic patients. METHODS: HRM studies of asymptomatic and symptomatic individuals from several centers of Spain and Latin America were analyzed using both CC2.0 and CC3.0. The final diagnosis was grouped into hierarchical categories: obstruction (achalasia and gastro-esophageal junction obstruction), major disorders (distal esophageal spasm, absent peristalsis, and jackhammer), minor disorders (failed frequent peristalsis, weak peristalsis with small or large defects, ineffective esophageal motility, fragmented peristalsis, rapid contractile with normal latency and hypertensive peristalsis) and normal. The results were compared using McNemar's and Kappa tests. RESULTS: HRM was analyzed in 107 healthy volunteers (53.3% female; 18-69 years) and 400 symptomatic patients (58.5% female; 18-90 years). In healthy volunteers, using CC2.0 and CC3.0, obstructive disorders were diagnosed in 7.5% and 5.6%, respectively, major disorders in 1% and 2.8%, respectively, minor disorders in 25.2% and 15%, respectively, and normal in 66.4% and 76.6%, respectively. In symptomatic individuals, using CC2.0 and CC3.0, obstructive disorders were diagnosed in 11% and 11.3%, respectively, major disorders in 14% and 14%, respectively, minor disorders in 33.3% and 24.5%, respectively, and normal in 41.8% and 50.3%, respectively. In both groups of individuals, only an increase in normal and a decrease in minor findings using CC3.0 were statistically significant using McNemar's test. DISCUSSIONS: CC3.0 increases the number of normal studies when compared with CC2.0, essentially at the expense of fewer minor disorders, with no significant differences in major or obstructive disorders. As the relevance of minor disorders is questionable, our data suggest that CC3.0 increases the relevance of abnormal results.
OBJECTIVES: High-resolution manometry (HRM) is the preferred method for the evaluation of motility disorders. Recently, an update of the diagnostic criteria (Chicago 3.0) has been published. The aim of this study was to compare the performance criteria of Chicago version 2.0 (CC2.0) vs. 3.0 (CC3.0) in a cohort of healthy volunteers and symptomatic patients. METHODS: HRM studies of asymptomatic and symptomatic individuals from several centers of Spain and Latin America were analyzed using both CC2.0 and CC3.0. The final diagnosis was grouped into hierarchical categories: obstruction (achalasia and gastro-esophageal junction obstruction), major disorders (distal esophageal spasm, absent peristalsis, and jackhammer), minor disorders (failed frequent peristalsis, weak peristalsis with small or large defects, ineffective esophageal motility, fragmented peristalsis, rapid contractile with normal latency and hypertensive peristalsis) and normal. The results were compared using McNemar's and Kappa tests. RESULTS: HRM was analyzed in 107 healthy volunteers (53.3% female; 18-69 years) and 400 symptomatic patients (58.5% female; 18-90 years). In healthy volunteers, using CC2.0 and CC3.0, obstructive disorders were diagnosed in 7.5% and 5.6%, respectively, major disorders in 1% and 2.8%, respectively, minor disorders in 25.2% and 15%, respectively, and normal in 66.4% and 76.6%, respectively. In symptomatic individuals, using CC2.0 and CC3.0, obstructive disorders were diagnosed in 11% and 11.3%, respectively, major disorders in 14% and 14%, respectively, minor disorders in 33.3% and 24.5%, respectively, and normal in 41.8% and 50.3%, respectively. In both groups of individuals, only an increase in normal and a decrease in minor findings using CC3.0 were statistically significant using McNemar's test. DISCUSSIONS: CC3.0 increases the number of normal studies when compared with CC2.0, essentially at the expense of fewer minor disorders, with no significant differences in major or obstructive disorders. As the relevance of minor disorders is questionable, our data suggest that CC3.0 increases the relevance of abnormal results.
Authors: Sudip K Ghosh; John E Pandolfino; Qing Zhang; Andrew Jarosz; Nimeesh Shah; Peter J Kahrilas Journal: Am J Physiol Gastrointest Liver Physiol Date: 2006-01-12 Impact factor: 4.052
Authors: Dustin A Carlson; Karthik Ravi; Peter J Kahrilas; C Prakash Gyawali; Arjan J Bredenoord; Donald O Castell; Stuart J Spechler; Magnus Halland; Navya Kanuri; David A Katzka; Cadman L Leggett; Sabine Roman; Jose B Saenz; Gregory S Sayuk; Alan C Wong; Rena Yadlapati; Jody D Ciolino; Mark R Fox; John E Pandolfino Journal: Am J Gastroenterol Date: 2015-06-02 Impact factor: 10.864
Authors: A J Bredenoord; M Fox; P J Kahrilas; J E Pandolfino; W Schwizer; A J P M Smout Journal: Neurogastroenterol Motil Date: 2012-03 Impact factor: 3.598
Authors: S Kuribayashi; K Iwakiri; A Kawada; N Kawami; S Hoshino; N Takenouchi; H Hosaka; Y Shimoyama; O Kawamura; M Yamada; M Kusano Journal: Neurogastroenterol Motil Date: 2014-10-01 Impact factor: 3.598
Authors: A Lazarescu; G Karamanolis; L Aprile; R B De Oliveira; R Dantas; D Sifrim Journal: Neurogastroenterol Motil Date: 2010-08-16 Impact factor: 3.598
Authors: Ishita Dhawan; Brendon O'Connell; Amit Patel; Ron Schey; Henry P Parkman; Frank Friedenberg Journal: Dig Dis Sci Date: 2018-12 Impact factor: 3.199